U.S. market Open. Closes in 3 hours 5 minutes

RDY | Dr. Reddy's Laboratories Limited Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for RDY we got that it has average fundamentals where Valuation is considered to be undervalued, Profitability is very wealthy, Growth is good and Health is strong.

Valuation (71%)

Company Industry
P/E Ratio (TTM) 19.97 24.35
PEG Ratio (TTM) 1.60 2.26
P/S Ratio (TTM) 3.84 5.44
P/B Ratio (TTM) 3.77 5.08
P/FCF Ratio (TTM) 52.80 11.30
Price to 5YR AVG Earnings Ratio 0.41 5.19
Price to 5YR AVG FCF Ratio 0.58 24.02

Profitability (75%)

Company Industry
ROA (TTM) 13.38% 3.23%
ROE (TTM) 20.28% 30.89%
Net Profit Margin (TTM) 19.26% -9.94%
ROIC 5YR AVG 25.06% 10.88%

Growth (62%)

4QTR AVG 3YR AVG 5YR AVG
EPS 0.00% 9.63% 28.69%
Revenue 3.37% 11.72% 12.68%
Net Income 0.00% 9.62% 28.73%
Cash Flow 25.68% 0.78% 17.79%

Health (63%)

Company Industry
Current Ratio (TTM) 2.55 2.50
Quick Ratio (TTM) 1.90 1.84
D/E Ratio (TTM) 0.10 -0.02
Interest Coverage (TTM) 50.63 12.10
Piotroski F-Score 4 6
Altman Z-Score 2.76 4.76
LTL to 5YR AVG FCF 0.26 4.47
Shares Outstanding Growth 5YR AVG 0.06% 28.67%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙